{"url_path":"/sec/rgpx/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1357878/0001472375-26-000167-index.html","accession_number":"0001472375-26-000167","cik":"0001357878","ticker":"RGPX","issuer_name":"REGENEREX PHARMA, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1357878/0001472375-26-000167-index.html","primary_entity_key":"0001357878","primary_entity_name":"REGENEREX PHARMA, INC."},"word_count":84,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.** \n\n \n\n(d)\n\nExhibits.\n\n \n\n**Exhibit No.**\n\n \n\n**Exhibit Description**\n\n[99.1*](exhibit99-1.htm)\n\n \n\n[Litigation update](exhibit99-1.htm)[ dated June 5, 2026](exhibit99-1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n  \n\n* Filed herewith.\n\n** Furnished herewith.\n\n**SIGNATURES**\n\n** **\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly\ncaused this Report to be signed on its behalf by the undersigned, hereunto duly\nauthorized.\n\n \n\n \n\n**REGENEREX PHARMA, INC.**\n\n \n\n \n\n \n\n \n\nBy:\n\n*/s/ Greg\nPilant*\n\nDate: June 11,\n2026\n\nName:\n\nGreg Pilant\n\n \n\nTitle:\n\nChief Executive\nOfficer"}